Article info
PDFPostScript
Letter to the editor
Effects of omalizumab in Aspergillus-associated airway disease
- Correspondence to Luis A Pérez de Llano, Pneumology Service, Hospital Xeral-Calde, c/Dr Ochoa, s/n, Lugo 27004, Spain; eremos26{at}hotmail.com
Citation
Effects of omalizumab in Aspergillus-associated airway disease
Publication history
- Accepted January 19, 2011
- First published March 11, 2011.
Online issue publication
September 01, 2022
Article Versions
- Previous version (29 April 2016).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© 2011, Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions.